Phased 20-30% TXN trim with corrected execution and conditional re-entry triggers
The synthesis prescribes disciplined action: the phased trim with corrected execution (stop BELOW entry, not above) captures the macro protection the regime demands without paying the transaction cost of a poorly specified single-shot order on binary-catalyst day. Three of four analytical lenses support trimming: hostile macro (96% Polymarket hike odds, 10Y at 2007 highs >5%, oil at $105, recession odds +12.5pp to 20%), confirmed technical breakdown (-24% from $332 to $253, price below declining 50 SMA at $275.71, MACD negative at -3.73), and stretched TTM valuation ($240B market cap on 2022-level revenue, forward P/E of 24.7x embeds seven simultaneous assumptions). Prior 9/8 and 9/10 trim failures at similar technical configurations (both cost alpha when relief rallies extended) inform the corrected two-phase approach rather than a single-shot trim into speculative strength.
| Position | Action |
|---|---|
| Any relief-rally strength above $265 | Trim 10-15% of TXN position (Phase 1) with hard stop at $258 on closing basis |
| Fed reaction prints AND price confirms weakness (close below $258 on >5M volume OR 10Y yields stay >5%) | Trim another 10-15% of TXN position (Phase 2) |
TXN is at a fundamental inflection driven by Q2 2026 structural breaks in revenue, margins, and FCF, supported by ASP hikes, capex rollover, and a fortress balance sheet, making the current technical basing pattern a launchpad for higher prices rather than a top.
| Indicator | Value | Signal |
|---|---|---|
| 200 SMA | $240.68 | bullish |
| 50 SMA | $275.71 | bearish |
| 10 EMA | $262.00 | bullish |
| MACD Line | -3.73 | neutral |
| MACD Signal | -5.26 | neutral |
| MACD Histogram | +1.53 | bullish |
| RSI | 47.45 | neutral |
| Bollinger Upper Band | $271.55 | neutral |
| Bollinger Middle Band (20 SMA) | $261.59 | neutral |
| Bollinger Lower Band | $251.63 | neutral |
| ATR |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: $240-242 retest of 200 SMA
Then: Consider re-engagement on significant technical support
Forward valuation metrics indicate the market hasn't caught up to the FCF ramp
↩ rebuts: “Bear's claim of extended valuation”
EV: +5.7% · concedes: D&A rising as headwind to GAAP earnings is true but transitory — Q2'26 already showed 42.6% operating margin despite D&A drag, and as utilization ramps this powers the next leg of FCF; China/geopolitical risk is real but priced; TXN's industrial-heavy mix is among the least exposed to direct consumer/AI China demand shocks
TXN's Q2 2026 performance is cyclical mean reversion to ~80% of the FY2022 peak, not a structural break—the current $240B market cap already prices in a structural premium versus the $170B peak achieved when revenue was essentially the same.
· concedes: The 300mm ramp is real—acknowledges this is a legitimate product/execution point; Q2 was a strong beat (+23% YoY, +350 bps margin)
→ vs conservative: 25-year dividend growth is backward-looking; fortress balance sheet buys slower bleed not protection under macro stress; Q2'26's +23% YoY base effect becomes a headwind in Q3; forward P/E of 24.7x faces 20-25% compression on any support breach; stock at 18x versus 24x means 'income plus appreciation' becomes 'income plus permanent impairment'
→ vs neutral: MACD histogram +1.53 at negative 3.73 line is deceleration of selling not reversal; 'bullish divergence' at 24% breakdown from $332 to $253 is meaningless until proven otherwise; waiting for confirmation means buying back at $285 not $268; neutral misses both relief-rally exit and post-hike downside capture; 200 SMA at $240.68 is a lagging rearview mirror indicator
| $8.66 |
| neutral |
Support: 251.63 · 258 · 240.68 | Resistance: 268.7 · 271.55 · 275.71
TXN exhibits a composite bias of base-to-early reversal with a cautiously bullish outlook; the long-term 200 SMA trend remains intact and bullish with price ~9.4% above that level, while the medium-term 50 SMA trend is bearish and declining. Short-term momentum has inflected positively as the MACD histogram crossed into positive territory (+1.53) and price reclaimed the 10 EMA, though the MACD line has yet to cross above the signal line. Volatility has compressed significantly with Bollinger Bandwidth narrowing from ~$59 to ~$20, typically a precursor to directional breakout. Key trading scenarios favor waiting for confirmation—either a sustained close above $275.71 (50 SMA reclaim) or a successful higher-low retest of $251–$258—before committing full long exposure, with the base case projecting a range-bound consolidation between $252 and $276 while the 50 SMA converges toward price.
Market Cap
$240.6B
Revenue (TTM)
$19.45B
Net Income (TTM)
$6.02B
EPS (TTM)
$6.59
Forward EPS
$10.64
Free Cash Flow (TTM)
$3.55B
Operating Margin
42.6%
Profit Margin
31.1%
ROE
35.2%
ROA
13.1%
P/E (TTM)
39.97x
Forward P/E
24.75x
PEG Ratio
0.94
Price/Book
13.36x
EV/EBITDA (TTM)
~26.4x
Dividend Yield
2.16%
Beta
1.31
52-Week High
$334.03
52-Week Low
$152.73
50-Day Moving Average
$277.05
200-Day Moving Average
$241.99
Cash & ST Investments (Q2'26)
$7.00B
Total Debt (Q2'26)
$14.05B
Net Debt (Q2'26)
$10.39B
Stockholders' Equity (Q2'26)
$18.01B
Current Ratio (Q2'26)
4.86
Working Capital (Q2'26)
$12.51B
FY25 Capex
$4.55B
FY24 Capex
$4.82B
FY23 Capex
$5.07B
Q2'26 Capex
$514M
FY25 Revenue
$17.68B
FY24 Revenue
$15.64B
FY25 Net Income
$5.00B
FY24 Net Income
$4.80B
FY25 Dividends Paid
$5.00B
FY25 Buybacks
$1.48B
FY25 Total Returned to Shareholders
$6.48B
FY25 D&A
$1.999B
Q2'26 Revenue
$5.46B
Q2'26 Gross Margin
61.4%
Q2'26 Net Income
$1.98B
Q2'26 EPS
$2.14
Q2'26 Free Cash Flow
$2.19B
FY25 Operating Cash Flow
$7.15B
Q2'26 Dividend (quarterly)
$1.295B
Gross PP&E
$17.86B
Revenue CAGR (FY21-FY25)
-0.9%
Net Income CAGR (FY21-FY25)
-10.4%
Strengths
Concerns
TXN is in the early innings of a major cyclical recovery combined with structural margin expansion driven by its 300mm capacity build-out. Q2 2026 confirmed the inflection with revenue +23% YoY to $5.46B, gross margin up 350 bps QoQ to 61.4%, and FCF hitting $2.19B (multi-year high) as capex peaked and declined to $514M. The valuation appears expensive on trailing metrics (~40x P/E) but reasonable on forward metrics (~24.7x P/E, PEG < 1.0) given ~62% expected earnings growth. With a fortress balance sheet ($7B cash, 4.86x current ratio), growing 2.16% dividend with 25+ years of consecutive increases, and aggressive shareholder returns ($6.48B returned in FY25), TXN remains a high-quality semiconductor holding with a compelling setup—though traders should respect the cyclicality (beta 1.31) and proximity to 52-week highs.
Macro: A regime change in monetary policy expectations: Polymarket-implied Fed rate hike probability surged to 96% for 2026 (+25.0pp WoW), with 86% priced for a hike at today's Sept 15 meeting (+31.5pp WoW). The simultaneous surge in hike odds and US recession odds (20%, +12.5pp WoW) signals a stagflationary regime, confirmed by 10-year Treasury yields hitting their highest since 2007 (briefly above 5%), oil back above $100 and hitting $105, and sticky inflation across multiple reports. The early-September "macro relief" that lifted chip names has fully reversed, with rising yields and energy costs re-pressuring the sector.